Racial differences in serum chemokines in prostate cancer patients

被引:5
作者
Karan, Dev [1 ,2 ,5 ,6 ]
Wick, Jo [3 ]
Dubey, Seema [1 ,2 ]
Kumar-Sinha, Chandan [4 ]
Siddiqui, Javed [4 ]
Kunju, Lakshmi P. [4 ]
Iczkowski, Kenneth A. [1 ]
Chinnaiyan, Arul M. [4 ]
机构
[1] Med Coll Wisconsin, MCW Canc Ctr, Dept Pathol, Milwaukee, WI USA
[2] Med Coll Wisconsin, Prostate Canc Ctr Excellence, Milwaukee, WI USA
[3] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Kansas City, KS USA
[4] Univ Michigan, Dept Pathol, Michigan Ctr Translat Pathol, Ann Arbor, MI USA
[5] Med Coll Wisconsin, MCW Canc Ctr, Dept Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[6] Med Coll Wisconsin, Prostate Canc Ctr Excellence, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
关键词
CCL23; chemokines profile; CXCL2; CXCL5; prostate cancer; racial disparity; DUFFY ANTIGEN/RECEPTOR; AFRICAN-AMERICAN; CXCL5; PROLIFERATION; MIGRATION; CELLS; DARC;
D O I
10.1002/cncr.35012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThis study aimed to understand the differential levels of inflammatory chemokines in association with higher prostate cancer incidence and mortality in African American (AA) men than in Caucasians (CA).MethodsThe authors used a chemokine assay to simultaneously measure 40 chemokines and cytokines levels in the serum of preoperative prostate cancer patients and healthy controls of AA and CA races. Selected chemokines (CXCL2, CXCL5, and CCL23) serum level was validated in 211 serum samples from prostate cancer patients and healthy controls. Differential expression of CXCL5 and CCL23 was analyzed using immunohistochemistry in a representative cohort of prostate tumor tissues of AA and CA races.ResultsRace-specific comparisons from 211 serum samples showed significantly higher levels of CXCL2 (control: 3104.0 pg/mL vs. cancer: 2451.0 pg/mL) and CXCL5 (control: 5189.0 pg/mL vs. cancer: 5459.0 pg/mL) in AA men than in CAs (CXCL2; control: 1155.0 pg/mL vs. cancer: 889.3 pg/mL, and CXCL5; control: 1183.0 pg/mL vs. cancer: 977.5 pg/mL). CCL23 differed significantly within and between the races with a lower level in AA cancer cases (454.5 vs. 966.6 pg/mL) than healthy controls (740.5 vs. 1263.0 pg/mL). Patient age, prostate-specific antigen, or Gleason scores were not significantly associated with these chemokines. Immunostaining for CXCL5 and CCL23 in a representative cohort of archival prostate tissues displayed significantly higher CXCL5 in prostate tumors than in adjacent benign tissues, whereas CCL23 was nondetectable in most of the analyzed tumor tissues.ConclusionLower levels of CCL23 in AA prostate cancer patient sera and tumor tissues and high CXCL2 and CXCL5 may contribute to aggressive prostate cancer, as often seen in AA men. The disproportionate levels of serum chemokines associated with race warrant further exploration to improve equitability in precision oncology to benefit prostate cancer patients. This study found that serum chemokines CXCL2, CXCL5, and CCL23 are the most prominent chemokines differentially expressed in men of African American and Caucasian races. The impact of such chemokines contributing to the disparity in prostate cancer biology among races needs further investigation.
引用
收藏
页码:3783 / 3789
页数:7
相关论文
共 51 条
[1]   Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer [J].
Awasthi, Shivanshu ;
Berglund, Anders ;
Abraham-Miranda, Julieta ;
Rounbehler, Robert J. ;
Kensler, Kevin ;
Serna, Amparo ;
Vidal, Adriana ;
You, Sungyong ;
Freeman, Michael R. ;
Davicioni, Elai ;
Liu, Yang ;
Karnes, R. Jeffrey ;
Klein, Eric A. ;
Den, Robert B. ;
Trock, Bruce J. ;
Campbell, Joshua D. ;
Einstein, David J. ;
Gupta, Raavi ;
Balk, Steven ;
Lal, Priti ;
Park, Jong Y. ;
Cleveland, John L. ;
Rebbeck, Timothy R. ;
Freedland, Stephen J. ;
Yamoah, Kosj .
CLINICAL CANCER RESEARCH, 2021, 27 (01) :320-329
[2]   CXCL5 promotes prostate cancer progression [J].
Begley, Lesa A. ;
Kasina, Sathish ;
Mehra, Rohit ;
Adsule, Shreelekha ;
Admon, Andrew J. ;
Lonigro, Robert J. ;
Chinnaiyan, Arul ;
Macoska, Jill .
NEOPLASIA, 2008, 10 (03) :244-254
[3]   Prediagnostic circulating inflammation-related biomarkers and gastric cancer: A case-cohort study in Japan [J].
Camargo, M. Constanza ;
Song, Minkyo ;
Sawada, Norie ;
Inoue, Manami ;
Shimazu, Taichi ;
Charvat, Hadrien ;
Pfeiffer, Ruth M. ;
Yamaji, Taiki ;
Tsugane, Shoichiro ;
Rabkin, Charles S. .
CYTOKINE, 2021, 144
[4]   CytokineDB: a database collecting biological information [J].
Costantini, Susan ;
Capone, Francesca ;
Miele, Marco ;
Guerriero, Eliana ;
Napolitano, Maria ;
Colonna, Giovanni ;
Castello, Giuseppe .
BIOINFORMATION, 2009, 4 (03) :92-93
[5]   Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC) [J].
Dawson, TC ;
Lentsch, AB ;
Wang, ZX ;
Cowhig, JE ;
Rot, A ;
Maeda, N ;
Peiper, SC .
BLOOD, 2000, 96 (05) :1681-1684
[6]   Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma [J].
Deng, Haijing ;
Kan, Anna ;
Lyu, Ning ;
He, Meng ;
Huang, Xin ;
Qiao, Shuang ;
Li, Shaolong ;
Lu, Wenhua ;
Xie, Qiankun ;
Chen, Huiming ;
Lai, Jinfa ;
Chen, Qifeng ;
Jiang, Xiongying ;
Liu, Shousheng ;
Zhang, Zhenfeng ;
Zhao, Ming .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
[7]   Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality [J].
Dess, Robert T. ;
Hartman, Holly E. ;
Mahal, Brandon A. ;
Soni, Payal D. ;
Jackson, William C. ;
Cooperberg, Matthew R. ;
Amling, Christopher L. ;
Aronson, William J. ;
Kane, Christopher J. ;
Terris, Martha K. ;
Zumsteg, Zachary S. ;
Butler, Santino ;
Osborne, Joseph R. ;
Morgan, Todd M. ;
Mehra, Rohit ;
Salami, Simpa S. ;
Kishan, Amar U. ;
Wang, Chenyang ;
Schaeffer, Edward M. ;
Roach, Mack, III ;
Pisansky, Thomas M. ;
Shipley, William U. ;
Freedland, Stephen J. ;
Sandler, Howard M. ;
Halabi, Susan ;
Feng, Felix Y. ;
Dignam, James J. ;
Nguyen, Paul L. ;
Schipper, Matthew J. ;
Spratt, Daniel E. .
JAMA ONCOLOGY, 2019, 5 (07) :975-983
[8]   Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer [J].
Di Mitri, Diletta ;
Mirenda, Michela ;
Vasilevska, Jelena ;
Calcinotto, Arianna ;
Delaleu, Nicolas ;
Revandkar, Ajinkya ;
Gil, Veronica ;
Boysen, Gunther ;
Losa, Marco ;
Mosole, Simone ;
Pasquini, Emiliano ;
D'Antuono, Rocco ;
Masetti, Michela ;
Zagato, Elena ;
Chiorino, Giovanna ;
Ostano, Paola ;
Rinaldi, Andrea ;
Gnetti, Letizia ;
Graupera, Mariona ;
Figueiredo Fonseca, Ana Raquel Martins ;
Mestre, Ricardo Pereira ;
Waugh, David ;
Barry, Simon ;
De Bono, Johann ;
Alimonti, Andrea .
CELL REPORTS, 2019, 28 (08) :2156-+
[9]   The human Duffy antigen binds selected inflammatory but not homeostatic chemokines [J].
Gardner, L ;
Patterson, AM ;
Ashton, BA ;
Stone, MA ;
Middleton, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (02) :306-312
[10]   Cancer statistics for African American/Black People 2022 [J].
Giaquinto, Angela N. ;
Miller, Kimberly D. ;
Tossas, Katherine Y. ;
Winn, Robert A. ;
Jemal, Ahmedin ;
Siegel, Rebecca L. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2022, 72 (03) :202-229